#obesity drugs

[ follow ]
#obesity-drugs

Hims & Hers Health stock tanks after FDA says competitor Eli Lilly's weight-loss drug shortage is over

Hims & Hers stock dropped nearly 10% due to FDA lifting drug shortages for competitor Eli Lilly, while its own semaglutide product remains unaffected.

Drugmakers say obesity medicine shortages are easing, but patients struggle to fill prescriptions

Many patients are struggling to find their medications due to ongoing shortages, despite recent claims from drug manufacturers that supplies have improved.

You've Lost Weight Taking New Obesity Drugs. What Happens if You Stop?

Patients who lose weight with obesity drugs face challenges and uncertainty on how to maintain their weight loss once they reach their goal.

An obesity pill study tested on just 25 patients led to a stunning $16.8 billion increase in Swiss drugmaker Roche's market value

Positive results in small trials for obesity drugs led to significant market value gains, driven by the large potential market size.

How to Get Off Ozempic

Obesity drugs may need to be taken indefinitely for weight maintenance, but some doctors are exploring short-term use with transition to cheaper alternatives for long-term maintenance.

A Drug Half as Good as Ozempic for One-30th the Price

New obesity drugs like GLP-1 receptor agonists are in the spotlight, but older medications also offer weight loss benefits.
There is a lack of awareness about older obesity drugs that have been effective for years prior to the introduction of newer medications like Ozempic and Wegovy.

Hims & Hers Health stock tanks after FDA says competitor Eli Lilly's weight-loss drug shortage is over

Hims & Hers stock dropped nearly 10% due to FDA lifting drug shortages for competitor Eli Lilly, while its own semaglutide product remains unaffected.

Drugmakers say obesity medicine shortages are easing, but patients struggle to fill prescriptions

Many patients are struggling to find their medications due to ongoing shortages, despite recent claims from drug manufacturers that supplies have improved.

You've Lost Weight Taking New Obesity Drugs. What Happens if You Stop?

Patients who lose weight with obesity drugs face challenges and uncertainty on how to maintain their weight loss once they reach their goal.

An obesity pill study tested on just 25 patients led to a stunning $16.8 billion increase in Swiss drugmaker Roche's market value

Positive results in small trials for obesity drugs led to significant market value gains, driven by the large potential market size.

How to Get Off Ozempic

Obesity drugs may need to be taken indefinitely for weight maintenance, but some doctors are exploring short-term use with transition to cheaper alternatives for long-term maintenance.

A Drug Half as Good as Ozempic for One-30th the Price

New obesity drugs like GLP-1 receptor agonists are in the spotlight, but older medications also offer weight loss benefits.
There is a lack of awareness about older obesity drugs that have been effective for years prior to the introduction of newer medications like Ozempic and Wegovy.
moreobesity-drugs

The Obesity-Drug Era Starts Now

Obesity drugs like Wegovy are becoming more accessible to patients and may become a routine part of healthcare.
A recent study shows that Wegovy can have profound effects on heart health, opening up the drug to more patients.
The FDA has approved another obesity drug, Zepbound, which may be more potent and cheaper than Wegovy.
[ Load more ]